As some have said in the good old days this announcement would have created a small frenzy in the share price . Unfortunately it seems the market is just not interested.
Probably due to the lack of trust now by shareholders.
The amount of money and time to get TAVR to market is going to be considerable and I will be very surprised to see any partnership be done at this early stage .
Why would someone partner up knowing that AHZ is a bit cash strapped? -why not sit back and wait to pick over the scraps .
Such a shame that AHZ thought they could take on the world on their own .
Should have licensed products out much earlier to a major health player and then just clipped the ticket .
I would be interested in buying AHZ again if major change in management, realistic wages for execs , approval of Cardiocel in Oz . Not sure if any of that will happen - new major shareholders may just end up taking the lot for a pittance .
I hate seeing investors lose
Ann: Promising Interim Results from TAVR Animal Study, page-45
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.55 |
Change
-0.130(1.11%) |
Mkt cap ! $244.1M | |||
| Open | High | Low | Value | Volume |
| $11.71 | $11.89 | $11.41 | $703.3K | 60.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $11.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.83 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |